Murer P

No ORCID on file · 1 paper in corpus · active 2019
2019
Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.
New biotechnology ·doi:10.1016/j.nbt.2019.04.002

Antibody-cytokine fusion proteins represent a novel class of biopharmaceuticals, with the potential to increase the therapeutic index of cytokine 'payloads' and to promote leukocyte infiltration at the site of disease. In this review, we pr…